Compare BTCS & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTCS | MLSS |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.8M | 42.6M |
| IPO Year | 2008 | 1996 |
| Metric | BTCS | MLSS |
|---|---|---|
| Price | $1.62 | $0.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $1.00 |
| AVG Volume (30 Days) | ★ 2.0M | 74.5K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,491,584.00 | $8,973,982.00 |
| Revenue This Year | $21.23 | $12.64 |
| Revenue Next Year | N/A | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 304.85 | 3.99 |
| 52 Week Low | $0.96 | $0.22 |
| 52 Week High | $6.15 | $0.60 |
| Indicator | BTCS | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 45.40 |
| Support Level | $1.46 | $0.24 |
| Resistance Level | $1.65 | $0.47 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 64.58 | 34.51 |
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.